What should I know first?
Bupropion is an antidepressant whose pharmacology differs from serotonin reuptake inhibitors. This lesson uses Wellbutrin XL, an extended-release bupropion hydrochloride tablet.
The U.S. Wellbutrin XL label covers major depressive disorder and prevention of seasonal major depressive episodes in people with seasonal affective disorder. This is not the smoking-cessation product label. Different formulations and uses require separate information.
This is a mechanism lesson, not a complete medicine guide. A diagram cannot choose treatment, predict your response, or tell you how to change a prescription.
How Brain Cells Communicate
Norepinephrine and dopamine are chemical messengers with their own transport systems. Returning a messenger into a nerve cell is called reuptake. This process is one part of signaling, not a direct measure of mood.
Dopamine · DAT
- Dopamine
The messenger is shown outside the sending cell.
- DAT
The DAT transporter returns dopamine into the cell.
- Return into the cell
The arrow shows transport direction, without a measured rate.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Norepinephrine · NET
- Norepinephrine
The messenger is shown outside the sending cell.
- NET
The NET transporter returns norepinephrine into the cell.
- Return into the cell
The arrow shows transport direction, without a measured rate.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
About this illustration
Norepinephrine and dopamine transporters return the respective messengers into cells. Each transporter is distinct.
How the Medication Changes Signaling
The product label describes bupropion as a relatively weak inhibitor of neuronal norepinephrine and dopamine uptake. It does not describe serotonin reuptake inhibition as its action.
The teaching symbol is qualitative. A weaker effect in an experimental measure cannot by itself establish weaker clinical benefit, or tell you how medicines compare for an individual.
Explore the mechanism
How does this example differ from serotonin reuptake inhibition?
Dopamine · DAT
- Dopamine
The messenger is shown outside the sending cell.
- DAT
The DAT transporter returns dopamine into the cell.
- Return into the cell
The arrow shows transport direction, without a measured rate.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Norepinephrine · NET
- Norepinephrine
The messenger is shown outside the sending cell.
- NET
The NET transporter returns norepinephrine into the cell.
- Return into the cell
The arrow shows transport direction, without a measured rate.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Dopamine · DAT
- Dopamine
The messenger is shown outside the sending cell.
- DAT
The DAT transporter returns dopamine into the cell.
- Return into the cell
The arrow shows transport direction, without a measured rate.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Norepinephrine · NET
- Norepinephrine
The messenger is shown outside the sending cell.
- NET
The NET transporter returns norepinephrine into the cell.
- Return into the cell
The arrow shows transport direction, without a measured rate.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Dopamine · DAT
- Dopamine
The messenger is shown outside the sending cell.
- DAT
The DAT transporter returns dopamine into the cell.
- Bupropion: uptake inhibited
The interrupted arrow names the action; the symbol is not a molecular shape or binding position.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Norepinephrine · NET
- Norepinephrine
The messenger is shown outside the sending cell.
- NET
The NET transporter returns norepinephrine into the cell.
- Bupropion: uptake inhibited
The interrupted arrow names the action; the symbol is not a molecular shape or binding position.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
What this model cannot tell us
Clinical mechanism unknown
- Clinical mechanism unknown The clinical explanation remains uncertain.
- Limits of inference An experimental result does not by itself predict one person’s treatment response.
Static overview. Start the steps when you are ready.
Reduced motion is on. Use the step buttons or read the complete sequence.
Guide to the illustration: Outlines identify a cell membrane or target; arrows mark the direction explained in each caption. Medicine symbols are labels, not measured shapes or binding poses. No quantity, size or rate is to scale.
Read the complete sequence
- Before medicine: uptake. Norepinephrine and dopamine transporters return the respective messengers into cells. Each transporter is distinct.
- With bupropion. Bupropion has relatively weak inhibitory effects on norepinephrine and dopamine uptake in the product pharmacology. The symbol is not a strength scale.
- What remains uncertain. The exact antidepressant mechanism remains unknown. This does not establish a simple messenger deficiency or rank medicines.
Evidence and model limits
Wellbutrin XL labeling distinguishes uptake effects from the unknown antidepressant mechanism. No cross-assay potency ranking is inferred.
Qualitative uptake model; it is not an SSRI diagram with a different name, a complete metabolite model, or a prediction of response.
A Closer Look at the Molecular Level
Known action: effects on norepinephrine and dopamine uptake are described in the pharmacology. Active metabolites also exist, so the parent medicine alone does not describe every aspect of exposure.
Clinical uncertainty: the precise antidepressant mechanism is unknown. This is not a diagram showing that depression is caused by low dopamine or norepinephrine. It gives no dose, transporter occupancy or complete prediction of effects.
Sources and References
The sources below support the specific medicine and experimental context described here. Drawings are original qualitative teaching models; positions, arrows and timing do not give atomic geometry, occupancy or rates.
Article Information
- Content updated
- 2026-10-16
- Sources checked
- 2026-10-16
- Publication status
- Published
Illustration information
- How does this example differ from serotonin reuptake inhibition?
Checked 2026-10-16 · Created for Psychiatry Atlas · Original project artwork

